Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trialRené Adam, Olivier Scatton, Victoire Granger et al.|The Lancet|2024Cited by 153
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of CirrhosisEléonora De Martin, Éric Vibert, M. Rayar et al.|Liver Transplantation|2020Cited by 122
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Caldéraro, Haeryoung Kim, Narmin Ghaffari Laleh et al.|Nature Communications|2023Cited by 76
Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trialRené Adam, M. Lewin, David Badrudin et al.|EClinicalMedicine|2024Cited by 34